Molecular epidemiology studies found UCP2 polymorphism alters the risk of developing CAD in some populations [33, 34], while the relation between UCPs and obesity was widely recognized in several populations [35–37]. Here, UCP2 is linked to obesity due to melanocortin 4 receptor deficiency.